An interventional study of Physical activation on Prescription in Ischemic Attack, Transient, sponsored by Tiohundra AB. Status unknown at 1 site in Sweden. Per ClinicalTrials.gov, last updated 2014-09-16.
Sponsored by Tiohundra AB · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Ischemic Attack, Transient with a site in Sweden — none open to participants now, none under way, none of them phase 3. Ischemic Attack, Transient · Sweden.
Among the 12 studies in Ischemic Attack, Transient with a site in Sweden, this one is the 10th largest by planned enrollment, is the only one that started in 2010, is one of 4 with no phase, and was the 4th registered.
330 studies on the registry are indexed under Ischemic Attack, Transient; 72 are open to participants now.
Browse Ischemic Attack, Transient studies →None of the 12 studies in Ischemic Attack, Transient with a site in Sweden is open now. The open studies under Ischemic Attack, Transient, anywhere →
Of the 56 Ischemic Attack, Transient studies recruiting now, 38 (68%) set no upper age limit and 6 (11%) stop at 75 or younger; 6 take children under 18; 9 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2010.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 220 across 179 interventional studies indexed under Ischemic Attack, Transient.
Median enrollment 1,090 across the 12 interventional studies. Of the 10 that completed or were terminated, 6 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 12 have an industry lead sponsor. The 7 most frequent:
Tiohundra AB is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Tiohundra AB has 1 study filed under Ischemic Attack, Transient — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Ischemic Attack, Transient with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine whether Physical Activation on Prescription can help patients with TIA to become more physically active.
One group will receives Physical Activation on Prescription (PaP)and the other group will receives usual care.
And to identify if persons with TIA presents with cognitive impairments.
Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group receives a PaP for 12 month.
Other: Physical activation on Prescription
The control group has the same monitoring as the experimental group but receives no PaP.
Before discharged from hospital cognitive function is assessed. At the first visit the patients fill in a self assessment questionnaire for mental fatigue. If impaired at the previous assessment cognitive function will be assessed at 3, 6 and 12 month.
In order to determine whether hospitalization in itself is associated with transient impaired cognition, a comparison group will be included. The comparison group will consist of patients with angina pectoris consecutively admitted to the Norrtälje Hospital. The patients with angina pectoris will be age and sex matched with the patients with TIA and assessed for cognitive function when their angina symptoms have subsided.
The advice on physical activity is patient oriented and based on FYSS (FYSS is a information bank that summarizes the up-to-date scientific knowledge on how to prevent and treat various diseases and conditions using physical activity). An individual prescription on physical activity is issued. The prescription form reminds of an ordinary drug prescription and provides specified types of physical activities including intensity, frequency and duration of the respective activities. The prescribed physical activity could be either self-monitored or organized by public physical activity organizations.
Also known as: PaP
Change in Physical activity over time
Physical activity measured with accelerometer (Time frame: Baseline, 3, 6, and 12 month).
Time frame: at discharge from hospital, 3, 6 and 12 month after the event
Change in Cognition and Mental Fatigue
Change in mental conditions over time measured with self report of mental fatigue and related symptoms. This is a scale with 7 different steps for graduate mental fatigue. Less points indicate less mental fatigue.
Time frame: All measures at baseline 3, 6 and 12 month after the event
Change in 6 MWT
Change in Walking endurance measured in 3, 6, 12 month measured with 6 MWT (six minutes Walking Test).
Time frame: 3, 6 and 12 months
Change in self reported stages of change
A self reported questionnaire that measures willingness to changes in physical activity over time. The scale has different levels of willingness for changes in physical activity.
Time frame: 3, 6, 12 months
Change from baseline in systolic blood pressure at 12 months
Time frame: 3, 6, 12 months
BMI
Body Mass Index is measured at the start and at the end of the study
Time frame: 12 months
Change in mental capacity over a period of time
Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity.
Time frame: 3, 6,12 months
Change in mental capacity over a period of time
Change in mental capacity measured with a assessment called Cognistat that indicates four different levels of mental capacity.
Time frame: 3, 6, 12 months
The record gives a start of May 2010, a primary completion of Apr 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tiohundra AB